13 — HUTCHMED (China) Cashflow Statement
0.000.00%
Last trade - 00:00- HK$20.35bn
- HK$14.66bn
- $630.20m
Annual cashflow statement for HUTCHMED (China), fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -116 | -167 | -360 | 101 | 38.2 |
| Depreciation | |||||
| Non-Cash Items | -68.6 | -127 | -17.3 | -4.54 | -22.8 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 116 | 82.4 | 100 | 114 | -27.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -62.1 | -204 | -269 | 219 | 0.497 |
| Capital Expenditures | -19.6 | -16.8 | -36.7 | -32.6 | -17.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -106 | -290 | 333 | -259 | -78.1 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -125 | -306 | 297 | -291 | -96.1 |
| Financing Cash Flow Items | -9.6 | -39.4 | -25.7 | -9.07 | -1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 296 | 650 | -82.8 | 48.7 | -30.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 114 | 142 | -64.3 | -29.7 | -130 |